We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Eli Lilly v. Apotex
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 4 2009

The Court dismissed the application for prohibition on the basis that the allegations of anticipation, obviousness, claims broader and Gillette defence are justified


Eli Lilly v. Apotex
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 4 2009

In the underlying decision on the merits, the Federal Court dismissed the application on the basis that the allegation as to a lack of sound prediction because the patent lacks adequate disclosure was justified


Eli Lilly v. Novopharm
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 4 2009

The Court dismissed the proceeding, finding the allegation of non-infringement justified, as well as the allegation as to invalidity based on utility justified


Sanofi Aventis v. Apotex
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 4 2009

Two days after the completion of the evidentiary phase of a trial on the merits, Apotex brought a motion to admit approximately 3,000 pages of evidence consisting of affidavits sworn in other Federal Court proceedings, transcripts from U.S. depositions and file history information for certain Canadian and U.S. patents


Bayer v. Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register


Apotex v. Canada (Minister of Health)
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin


Lundbeck v. Ratiopharm and Cobalt
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review


Eli Lilly v. Canada (Minister of Health)
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

Eli Lilly had submitted patent lists seeking to add the newly issued patent at issue to the Patent Register with respect to several supplemental new drug submissions


Novopharm Limited v. Eli Lilly Canada Inc
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal dismissed the appeal of the generic company from a decision of the motions judge refusing to dismiss the proceeding as a whole


Federal Court of Appeal upholds denial of innovator profits and refuses to grant damages for future lost market share in first case under s. 8 of the PM(NOC) Regulations
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 5 2009

In September 2008, the Federal Court released its first decision interpreting s. 8 of the PM(NOC) Regulations